Seelos Therapeutics Inc (SEEL)
0.72
+0.02
(+2.86%)
USD |
OTCM |
Nov 14, 16:00
Seelos Therapeutics Total Return Level: 0.72 for Nov. 14, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
November 14, 2024 | 0.72 |
November 13, 2024 | 0.70 |
November 12, 2024 | 0.71 |
November 11, 2024 | 0.73 |
November 08, 2024 | 0.7188 |
November 07, 2024 | 0.70 |
November 06, 2024 | 0.6845 |
November 05, 2024 | 0.69 |
November 04, 2024 | 0.92 |
November 01, 2024 | 1.03 |
October 31, 2024 | 1.02 |
October 30, 2024 | 1.10 |
October 29, 2024 | 0.99 |
October 28, 2024 | 1.27 |
October 25, 2024 | 1.22 |
October 24, 2024 | 1.18 |
October 23, 2024 | 1.15 |
October 22, 2024 | 1.20 |
October 21, 2024 | 1.13 |
October 18, 2024 | 1.01 |
October 17, 2024 | 1.01 |
October 16, 2024 | 1.17 |
October 15, 2024 | 1.28 |
October 14, 2024 | 2.45 |
October 11, 2024 | 2.43 |
Date | Value |
---|---|
October 10, 2024 | 2.47 |
October 09, 2024 | 2.91 |
October 08, 2024 | 3.20 |
October 07, 2024 | 3.10 |
October 04, 2024 | 3.41 |
October 03, 2024 | 3.00 |
October 02, 2024 | 3.27 |
October 01, 2024 | 3.22 |
September 30, 2024 | 3.755 |
September 27, 2024 | 3.90 |
September 26, 2024 | 5.00 |
September 25, 2024 | 5.411 |
September 24, 2024 | 4.784 |
September 23, 2024 | 3.04 |
September 20, 2024 | 3.206 |
September 19, 2024 | 3.261 |
September 18, 2024 | 3.186 |
September 17, 2024 | 3.60 |
September 16, 2024 | 2.978 |
September 13, 2024 | 3.184 |
September 12, 2024 | 3.032 |
September 11, 2024 | 3.248 |
September 10, 2024 | 3.24 |
September 09, 2024 | 3.36 |
September 06, 2024 | 3.648 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
0.6845
Minimum
Nov 06 2024
24268.80
Maximum
Apr 28 2021
4332.03
Average
3478.27
Median
Total Return Level Benchmarks
180 Life Sciences Corp | 2.89 |
Cassava Sciences Inc | 42.60 |
Cara Therapeutics Inc | 0.3279 |
Citius Pharmaceuticals Inc | 0.3857 |
Moleculin Biotech Inc | 2.50 |